AKT1 and neoplasm: The phosphorylated Akt (Fig. 4a), as well as the 5-bromo-2′-deoxyuridine (BrdU)-positive cells (Fig. 4b) were significantly reduced in tumour specimens from mice treated with IC87114 compared with vehicle, indicating reduced survival and proliferative rate of tumours upon p110δ inhibition.